Orange Book product
ORPHENADRINE CITRATE 30MG/ML
Orange Book ANDA 084779 · WATSON LABORATORIES INC · Prescription
Key facts
| Proprietary name | ORPHENADRINE CITRATE |
|---|---|
| Active ingredients | ORPHENADRINE CITRATE |
| Strength | 30MG/ML |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Application | ANDA084779 |
| Applicant holder | WATSON LABORATORIES INC |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AP |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Mar 15, 1982 |
At a glance
- 1–9 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.